What is the NOAEL for 4-Nitro-1,2-phenylenediamine?
4-Nitro-1,2-phenylenediamine has 26 NOAEL studies in the database. The lowest reported value is 0.042 mg/kg via oral in rat. Source: SCCS Opinion.
Also known as: 4-Nitro-o-phenylenediamine, 4-13-00-00075, BRN 0608106, EINECS 202-766-3, NCI-C03941 (+8 more)
CAS 99-56-9
4-Nitro-1,2-phenylenediamine (CAS 99-56-9) is a chemical substance; key hazard signal: IARC Group 3. Key regulatory status: 1 regulatory/inventory list, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, SCCS, IARC, ILO ICSC.
View cosmetic safety profile for 4-Nitro-O-Phenylenediamine →
CAS, identifiers, formula, and alternate names for the matched substance record.
Carcinogenic hazard classification from IARC monograph evaluations.
| Group | Meaning | Evaluated | Volume |
|---|---|---|---|
| Group 3 | Not classifiable | 1987 | 16, Sup 7 |
International Chemical Safety Card hazard and exposure summary.
| Field | Value |
|---|---|
| Long-term Effects | Repeated or prolonged contact may cause skin sensitization. |
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| Europe; Personal care; restricted | European Commission | CosIng |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 15 | mg/kg bw/day | - | oral | dog | Regulatory source |
| 45 | mg/kg/day | - | - | rat | Regulatory source |
| 45 | mg/kg bw/day | - | - | - | Regulatory source |
| 500 | mg/kg | - | oral | rat | Regulatory source |
| 5A9AX7Y0TT | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 3 | IARC group | IARC carcinogenicity classification | - | - | IARC Monographs |
| 3 | unitless | IARC group | - | - | NTP ICE cancer |
| =0.042 | mg/kg | NOAEL | oral | rat | SCCS Opinion |
| =15 | mg/kg bw/d | NOAEL | dermal | rat | CIR Safety Assessment |
| =15 | mg/kg bw/day | NOAEL | oral | dog | SCCS Opinion |
| =15 | mg/kg | NOAEL | oral | rat | SCCS Opinion |
| =45 | mg/kg bw/d | NOAEL | dermal | rat | CIR Safety Assessment |
| =45 | mg/kg/day | NOAEL | - | rat | SCCS Opinion |
| =45 | mg/kg bw/day | NOAEL | - | - | SCCS Opinion |
| =65 | % | NOAEL | oral | - | SCCS Opinion |
| =265 | mg/kg/day | NOAEL | - | - | SCCS Opinion |
| =500 | mg/kg | NOAEL | oral | rat | SCCS Opinion |
| =340 | mg/kg bw/day | NOEL | oral | Rat | ToxValDB ECOTOX |
| =500 | mg/kg bw/day | NOEL | oral | Mouse | ToxValDB ECOTOX |
| 750 | ppm | Top dose | - | Rat | NTP ICE cancer |
| 7500 | ppm | Top dose | - | Mouse | NTP ICE cancer |
| =0.042 | mg/kg | dermal absorption | oral | rat | Regulatory source |
| =15 | mg/kg | dermal absorption | oral | rat | Regulatory source |
| 15 | mg/kg bw/day | developmental toxicity | oral | rat | Regulatory source |
| 265 | mg/kg/day | developmental toxicity | - | - | Regulatory source |
| 65 | % | reproductive toxicity | oral | - | Regulatory source |
Showing 26 of 26 studies
Australian industrial chemicals inventory status and applicable conditions.
EU Scientific Committee opinions tied to the matched substance.
| Opinion | Date | Conclusion | Max Conc. | Concerns |
|---|---|---|---|---|
| SCCP/1006/06 | 19 December 2006 | not safe | - | genotoxicity; low MoS |
| SCCP/0980/06 | 2006-12-19 | Based on the information provided, the SCCP is of the opinion that the use of 4-Nitro-o-phenylenediamine itself as an oxidative hair dye substance at a maximum concentration of 0.5% in the finished cosmetic product (after mixing with hydrogen peroxide) does not pose a risk to the health of the consumer, apart from its sensitising potential. | 0.5% | Sensitising potential (extremely potent skin sensitiser). Induces mutations in Salmonella in vitro, but not genotoxic in vivo; genotoxicity/mutagenicity studies on finished hair dye formulations still required. IARC Group 3. |
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
4-Nitro-1,2-phenylenediamine has 26 NOAEL studies in the database. The lowest reported value is 0.042 mg/kg via oral in rat. Source: SCCS Opinion.
4-Nitro-1,2-phenylenediamine appears on 1 regulatory/inventory list including Europe; Personal care; restricted. Source: EPA CPDat.
4-Nitro-1,2-phenylenediamine is classified by IARC as Group 3 — not classifiable as to its carcinogenicity to humans (evaluated 1987). Source: IARC Monographs on the Identification of Carcinogenic Hazards to Humans.
Yes, 4-Nitro-1,2-phenylenediamine is also indexed as a cosmetic ingredient under the name 4-Nitro-O-Phenylenediamine. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, IARC Monographs, ILO/WHO ICSC, CosIng / Ingredients DB, ChEMBL / DailyMed. All data traces to primary regulatory sources and is updated from official government databases.
4-Nitro-1,2-phenylenediamine also appears in cosmetics, pharmaceutical databases.